相关实验视频
Updated: Jul 14, 2026

04:17
Determining the Serum Stability of Human Adenosine Deaminase 1 Enzyme
Published on: September 27, 2024
在人类,牛和Plasmodium falciparum腺氨酸脱氨酶中的过渡状态变化
Minkui Luo1, Vipender Singh, Erika A Taylor
1Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Journal of the American Chemical Society
|June 1, 2007
概括
研究人类,牛和Plasmodium falciparum的腺脱氨酶 (ADA) 发现了不同的过渡状态. 这些发现为疟疾治疗和免疫系统研究的ADA抑制剂设计提供了洞察力.
科学领域:
- 生物化学和酶学 生物化学和酶学
- 结构生物学是结构生物学.
- 药品化学 药品化学 是一个
背景情况:
- 腺脱氨酶 (ADA) 是人类和寄生虫生物学中的关键酶.
- 人类的ADA (HsADA) 对免疫细胞发育至关重要.
- 疟原虫 ADA (PfADA) 对于疟原虫的生存至关重要,使其成为治疗点.
研究的目的:
- 阐明人类,牛和Plasmodium falciparum中的腺脱氨酶 (ADA) 的过渡状态结构.
- 了解这些ADA之间的催化效率差异的结构基础.
- 为治疗应用,特别是疟疾的新型ADA抑制剂的设计提供信息.
主要方法:
- 使用具有竞争性的动态同位素效应 (KIEs) 与同位素标记的腺基质 ([6-13C], [6-15N], [1-15N]).
- 合成特定标记的腺因和核糖前体,用于基质制备.
- 运用密度函数理论 (DFT) 计算来建模和分析过渡状态结构.
主要成果:
- 通过使用KIEs和计算建模,确定PfADA,HSADA和牛ADA (BtADA) 的不同的过渡状态结构.
- 在所有研究的ADAs中观察到早期的SNR过渡状态,其特点是部分N1质子化和显著的核攻击.
- 过渡状态发展的量化变化,PfADA显示最早的过渡状态,BtADA显示最先进的过渡状态,与催化率相关.
结论:
- 过渡状态的结构差异解释了PfADA,HSADA和BtADA的不同催化效率.
- 对于选择性抗疟疾药物开发而言,PfADA独特的过渡状态提供了一个有希望的目标.
- 了解这些过渡状态有助于推进强效和特定的ADA抑制剂的合理设计.
相关概念视频
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
RNA Editing
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
ATP Synthase: Structure
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...

